| scholarly article | Q13442814 |
| P2093 | author name string | Ching-Feng Weng | |
| Sabrina Fan | |||
| P2860 | cites work | Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver | Q68876818 |
| Effect of S-adenosyl-L-methionine on thioacetamide-induced liver damage in rats | Q69581218 | ||
| Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model | Q69850266 | ||
| Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone | Q70272539 | ||
| Contribution of sinusoidal endothelial liver cells to liver fibrosis: expression of transforming growth factor-beta 1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-beta 1 | Q70496879 | ||
| Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells | Q70767689 | ||
| Interrelationship between in vivo lipid peroxidation, microsomal Ca2+-sequestration activity and hepatotoxicity in rats treated with carbon tetrachloride, cumene hydroperoxide or thioacetamide | Q71051877 | ||
| Nature of the toxicity of cyclosporin A in the rat | Q71061592 | ||
| Transforming growth factor beta 1-regulated gene expression of Ito cells | Q71216112 | ||
| Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide | Q71373979 | ||
| Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport | Q72685803 | ||
| Evaluation of liver function after thioacetamide treatment of partially hepatectomized rabbits | Q72838601 | ||
| Cyclosporine a augments P-glycoprotein expression in the regenerating rat liver | Q73068301 | ||
| Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats | Q73283025 | ||
| Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis | Q73869403 | ||
| Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia | Q77220651 | ||
| Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system | Q77429987 | ||
| Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1 | Q77932181 | ||
| In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506 | Q77936668 | ||
| The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure | Q78053124 | ||
| COMPOUNDS FOR CONTROL OF ORANGE DECAYS | Q81147679 | ||
| Fibroblast growth factors | Q24542507 | ||
| Fibroblast growth factors, their receptors and signaling | Q28140520 | ||
| Hepatic stellate cells: a target for the treatment of liver fibrosis | Q28140573 | ||
| Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase | Q28144405 | ||
| Structural and functional diversity in the FGF receptor multigene family | Q28265126 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system | Q28330781 | ||
| A transforming growth factor beta type I receptor that signals to activate gene expression | Q28576285 | ||
| From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. | Q30328533 | ||
| Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis | Q34252968 | ||
| Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions | Q34480115 | ||
| Roles of TGF-beta in hepatic fibrosis | Q34565570 | ||
| Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis | Q35792203 | ||
| Malic enzyme and glucose 6-phosphate dehydrogenase gene expression increases in rat liver cirrhogenesis. | Q36116118 | ||
| In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis | Q36220782 | ||
| Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA | Q36351854 | ||
| Molecular characterization of rat transforming growth factor-beta type II receptor | Q36770981 | ||
| Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice | Q37375446 | ||
| Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway | Q38349140 | ||
| Liver fibrosis and extracellular matrix | Q38606427 | ||
| Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes | Q39208062 | ||
| Toxicological evaluation of cyclosporin A. | Q40155197 | ||
| Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. | Q40477140 | ||
| The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis | Q40767646 | ||
| Expression of connective tissue growth factor in experimental rat and human liver fibrosis | Q40926848 | ||
| Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis | Q41228197 | ||
| Collagen types in normal and cirrhotic liver | Q41447374 | ||
| Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor | Q41544978 | ||
| The heparan sulfate-fibroblast growth factor family: diversity of structure and function. | Q41680432 | ||
| Cyclosporine augments hepatic regenerative response in rats | Q42013080 | ||
| Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver | Q42283352 | ||
| Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver | Q42480298 | ||
| Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study | Q43742730 | ||
| The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo | Q44383140 | ||
| Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. | Q46591125 | ||
| Biological effects of cyclosporin A: a new antilymphocytic agent. 1976. | Q48910444 | ||
| Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. | Q51648926 | ||
| Augmentative effect of cyclosporin A on rat liver regeneration: influence on hepatocyte growth factor and transforming growth factor-beta(1). | Q53898441 | ||
| Differential expression of transforming growth factor-beta and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration. | Q54140216 | ||
| Cyclosporine in the treatment of acute cadaveric kidney graft rejection refractory to high-dose methylprednisolone | Q54493612 | ||
| Structural and Functional Diversity in the FGf Receptor Multigene Family | Q55919452 | ||
| Modulation of thioacetamide-induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes | Q67909909 | ||
| Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy | Q67984653 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 1411-1419 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury | |
| P478 | volume | 11 |
| Q82944674 | Cyclosporine inhibits profibrotic effects of interleukin-4 and transforming growth factor β on human intrahepatic fibroblasts cultured in vitro |
| Q38706239 | Detrimental effects of nicotine on thioacetamide-induced liver injury in mice |
| Q50688552 | Down-regulation of TGFbeta1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats |
| Q39589755 | N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D. |
Search more.